Becton Dickinson and (BDX)
undefined
undefined%
At close: undefined
230.70
0.01%
After-hours Jan 06, 2025, 07:00 PM EST

Becton Dickinson and Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013Dec 31, 2012Sep 30, 2012Jun 30, 2012Mar 31, 2012Dec 31, 2011Sep 30, 2011Jun 30, 2011
Interventional Revenue 4.04B 2.10B 1.30B 1.29B 0 1.22B 1.19B 1.13B 0 1.14B 1.49B 1.11B 0 1.43B 1.01B 1.98B 0 782.00M 990.00M 1.01B 0 981.00M 963.00M 970.00M 1.13B 954.00M 1.10B 1.04B 1.05B 997.00M 982.00M 958.00M 997.00M 963.00M 936.00M 933.00M 2.08B 921.00M 945.00M 979.00M 301.00M 277.00M 302.00M 279.00M 300.69M 257.06M 279.36M 264.89M 155.31M 268.20M 339.61M 316.50M 1.00B 337.89M
Interventional Revenue Growth +92.24% +61.04% +1.24% n/a -100.00% +2.70% +5.05% n/a -100.00% -23.10% +33.18% n/a -100.00% +41.74% -48.91% n/a -100.00% -21.01% -2.17% n/a -100.00% +1.87% -0.72% -14.24% +18.55% -13.11% +5.07% -0.57% +5.42% +1.53% +2.51% -3.91% +3.53% +2.88% +0.32% -55.21% +126.17% -2.54% -3.47% +225.25% +8.66% -8.28% +8.24% -7.21% +16.97% -7.99% +5.46% +70.55% -42.09% -21.03% +7.30% -68.45% +196.92% n/a
Life Sciences Revenue 299.00M 2.30B 1.11B 1.05B 0 1.23B 1.27B 1.30B 0 1.31B 1.04B 1.48B 0 1.01B 1.59B 1.01B 0 951.00M 1.11B 1.12B 0 1.06B 1.05B 1.06B 1.11B 1.08B 2.17B 2.04B 2.12B 2.04B 1.99B 1.96B 2.23B 2.23B 2.13B 2.05B 977.00M 2.20B 1.11B 1.07B 1.90B 1.88B 1.77B 1.74B 1.15B 1.80B 2.05B 1.95B 2.01B 2.02B 1.96B 1.88B 5.71B 1.98B
Life Sciences Revenue Growth -87.00% +107.77% +5.23% n/a -100.00% -3.84% -2.07% n/a -100.00% +26.11% -30.01% n/a -100.00% -36.51% +57.34% n/a -100.00% -14.56% -0.89% n/a -100.00% +0.57% -0.38% -4.69% +2.69% -50.32% +6.73% -3.83% +3.83% +2.57% +1.17% -12.09% -0.04% +4.88% +3.75% +110.24% -55.57% +98.82% +3.17% -43.61% +1.12% +6.27% +1.90% +50.43% -35.73% -12.41% +4.99% -2.94% -0.47% +3.23% +4.41% -67.18% +188.95% n/a
Medical Revenue 5.82B n/a 489.00M 454.00M n/a 2.43B 2.36B 2.15B n/a 2.19B 450.00M 2.40B n/a 436.00M 2.31B 426.00M n/a 2.12B 2.15B 2.09B n/a 2.31B 2.18B 2.13B 2.16B 2.25B 952.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Medical Revenue Growth n/a n/a +7.71% n/a n/a +3.14% +9.56% n/a n/a +386.89% -81.23% n/a n/a -81.13% +442.49% n/a n/a -1.35% +2.92% n/a n/a +6.01% +2.11% -1.29% -3.70% +135.92% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Sep 30, 2024Sep 30, 2023Sep 30, 2022Sep 30, 2021Sep 30, 2020Sep 30, 2019Sep 30, 2018Sep 30, 2017Sep 30, 2016Sep 30, 2015Sep 30, 2014Sep 30, 2013Sep 30, 2012Sep 30, 2010
Asia Revenue 2.91B 2.91B 3.05B 3.27B 2.57B 2.73B 2.46B 1.74B 1.69B 1.54B 1.12B 1.01B 883.29M 684.32M
Asia Revenue Growth -0.24% -4.40% -6.88% +27.41% -5.80% +10.81% +41.06% +3.07% +9.51% +37.82% +11.43% +13.89% +29.08% n/a
Europe Revenue 4.40B 4.24B 4.04B 4.75B 3.48B 3.36B 3.30B 2.59B 3.05B 2.43B 2.73B 2.51B 2.38B 2.39B
Europe Revenue Growth +3.72% +4.97% -14.90% +36.52% +3.60% +1.85% +27.43% -15.12% +25.27% -10.94% +8.80% +5.60% -0.34% n/a
Others Country Revenue 1.21B 1.10B 1.06B 1.25B 1.35B 1.48B 1.46B 1.26B 849.00M 1.23B 1.18B 1.18B 1.16B 1.01B
Others Country Revenue Growth +9.53% +4.16% -15.70% -7.24% -8.33% +1.30% +15.91% +48.06% -31.20% +5.02% -0.68% +2.10% +14.21% n/a
United States Revenue 11.66B 11.11B 10.72B 10.97B 9.72B 9.73B 8.77B 6.50B 6.89B 5.07B 3.42B 3.35B 3.29B 3.29B
United States Revenue Growth +4.95% +3.65% -2.25% +12.90% -0.14% +10.97% +34.81% -5.64% +35.98% +48.35% +1.91% +1.99% +0.03% n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 1.26B 1.20B 1.19B 1.21B 1.14B 1.19B 1.21B 1.19B 1.18B 1.15B 1.23B 1.19B 1.33B 1.24B 1.15B 1.15B 1.20B 980.00M 1.02B 1.12B 1.09B 1.08B 1.09B 1.07B 1.10B 1.08B 1.06B 774.00M 774.00M 719.00M 724.00M 709.00M 796.00M 728.00M 732.00M 748.00M 756.00M 764.00M 511.00M
Selling, General, and Administrative Revenue Growth +5.02% +0.25% -1.65% +6.68% -4.45% -1.24% +1.52% +0.42% +2.87% -6.74% +3.97% -11.04% +7.68% +7.75% -0.09% -4.25% +22.45% -4.39% -8.56% +2.47% +1.67% -1.19% +1.49% -2.72% +2.04% +2.27% +36.56% n/a +7.65% -0.69% +2.12% -10.93% +9.34% -0.55% -2.14% -1.06% -1.05% +49.51% n/a
Research and Development Revenue 302.00M 299.00M 299.00M 290.00M 281.00M 306.00M 337.00M 313.00M 300.00M 315.00M 343.00M 314.00M 387.00M 344.00M 317.00M 291.00M 299.00M 262.00M 264.00M 270.00M 270.00M 282.00M 252.00M 258.00M 278.00M 277.00M 260.00M 192.00M 221.00M 186.00M 187.00M 182.00M 253.00M 207.00M 182.00M 187.00M 196.00M 178.00M 129.00M
Research and Development Revenue Growth +1.00% n/a +3.10% +3.20% -8.17% -9.20% +7.67% +4.33% -4.76% -8.16% +9.24% -18.86% +12.50% +8.52% +8.93% -2.68% +14.12% -0.76% -2.22% n/a -4.26% +11.90% -2.33% -7.19% +0.36% +6.54% +35.42% -13.12% +18.82% -0.53% +2.75% -28.06% +22.22% +13.74% -2.67% -4.59% +10.11% +37.98% n/a